Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (161-170 of 382) with videos related to

Pageof 39
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure RegistryJonathan De Blois, Morten Wang Fagerland, Morten Grundtvig, et al.
Scandinavian Cardiovascular Journal : SCJ|October 22, 2015
The role of medical and psychosocial factors for unfavourable coronary risk factor controlJohn Munkhaugen, Elise Sverre, Kari Peersen, et al.
Cardiovascular Research|June 14, 2002
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failureArne Yndestad, Jan Kristian Damås, Hans Geir Eiken, et al.
Circulation|May 11, 2005
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failureThor Ueland, Arne Yndestad, Erik Øie, et al.
Journal of Cardiac Failure|December 3, 2014
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trialThor Ueland, Pål Aukrust, Ståle H Nymo, et al.
Circulation|May 14, 2003
Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and plateletsJan Kristian Damås, Torgun Waehre, Arne Yndestad, et al.
Cardiovascular Diabetology|September 17, 2010
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitusJonas Hallén, Odd Erik Johansen, Kåre I Birkeland, et al.
American Heart Journal|December 1, 2012
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Lars Gullestad, Thor Ueland, John Kjekshus, et al.
Journal of Diabetes|October 7, 2010
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trialOdd Erik Johansen, Kåre Inge Birkeland, Anders Palmstrøm Jørgensen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2020
Long-term effects of high-intensity training vs moderate intensity training in heart transplant recipients: A 3-year follow-up study of the randomized-controlled HITTS studyKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.
Pageof 39

Showing results (161-170 of 382) with videos related to

Sort By:
Pageof 39
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure RegistryJonathan De Blois, Morten Wang Fagerland, Morten Grundtvig, et al.
Scandinavian Cardiovascular Journal : SCJ|October 22, 2015
The role of medical and psychosocial factors for unfavourable coronary risk factor controlJohn Munkhaugen, Elise Sverre, Kari Peersen, et al.
Cardiovascular Research|June 14, 2002
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failureArne Yndestad, Jan Kristian Damås, Hans Geir Eiken, et al.
Circulation|May 11, 2005
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failureThor Ueland, Arne Yndestad, Erik Øie, et al.
Journal of Cardiac Failure|December 3, 2014
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trialThor Ueland, Pål Aukrust, Ståle H Nymo, et al.
Circulation|May 14, 2003
Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and plateletsJan Kristian Damås, Torgun Waehre, Arne Yndestad, et al.
Cardiovascular Diabetology|September 17, 2010
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitusJonas Hallén, Odd Erik Johansen, Kåre I Birkeland, et al.
American Heart Journal|December 1, 2012
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Lars Gullestad, Thor Ueland, John Kjekshus, et al.
Journal of Diabetes|October 7, 2010
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trialOdd Erik Johansen, Kåre Inge Birkeland, Anders Palmstrøm Jørgensen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2020
Long-term effects of high-intensity training vs moderate intensity training in heart transplant recipients: A 3-year follow-up study of the randomized-controlled HITTS studyKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.
Pageof 39